Clinical Trials Browser

OTHER × N-dihydrogalactochitosan × Clear all

NCT03993678 2025-12-30

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

Phase 1/2 Completed

DermatologicSarcoma

Melanoma, Sarcoma

NCT06526338 2025-09-30

Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation Alone

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06630624 2025-07-03

INJECTABL-II

Phase 1/2 Recruiting

Gastrointestinal

Colorectal Neoplasms